| Literature DB >> 31606283 |
Lee-May Chen1, Stephanie V Blank2, Elizabeth Burton3, Karen Glass4, Emily Penick5, Terri Woodard6.
Abstract
Providers who care for women at risk for hereditary gynecologic cancers must consider the impact of these conditions on reproductive and hormonal health. This document reviews potential options for cancer prevention, family building, genetic testing and management of surgical menopause in this patient population. Capsule: Women predisposed to hereditary gynecologic cancer have options for fertility preservation, preimplantation genetic testing to select embryos without pathogenic variants, pregnancy through gestational carriers after hysterectomy and hormone replacement.Entities:
Keywords: Endometrial cancer; Genetic counseling; Menopause and hormone replacement therapy; Ovarian cancer; Quality of life issues
Mesh:
Year: 2019 PMID: 31606283 DOI: 10.1016/j.ygyno.2019.06.017
Source DB: PubMed Journal: Gynecol Oncol ISSN: 0090-8258 Impact factor: 5.482